Moxidectin 2mg Tablets | Study Design

Moxidectin Tablets FDA – BE Study Design


Regulatory Body FDA
Study Drug Information Test Product Reference Product
Strength  2mg Moxidectin tablets  2mg Moxidectin tablets
Formulation Tablets Tablets
Manufacturer Any Sponsor Medicines Development for Global Health 
Route Oral Oral
Therapeutic Indication Therapeutic Class: Anthelmintic drug
Therapeutic Indication: treatment of onchocerciasis due to Onchocerca volvulus in patients
aged 12 years and older.


Interested in the Full Study Design? Click below to download.

Schedule a Discovery Call

 Learn how BioPharma Services can be your trusted clinical trial partner.

You can unsubscribe at any time. For more details, please read our Privacy Policy.